Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel).

MLA

Franco, Fernando, et al. “Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel).” Current Oncology, vol. 28, no. 2, Apr. 2021, pp. 1249–55. EBSCOhost, https://doi.org/10.3390/curroncol28020118.

APA

Franco, F., Guirado, M., Martínez-Banaclocha, N., Gumà, J., Lavernia, J., Gómez-Codina, J., Rodriguez-Abreu, D., Martínez, F., Barrajón, E., Méndez, M., Calvo, V., & Provencio, M. (2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology, 28(2), 1249–1255. https://doi.org/10.3390/curroncol28020118

Chicago

Franco, Fernando, María Guirado, Natividad Martínez-Banaclocha, Josep Gumà, Javier Lavernia, José Gómez-Codina, Delvys Rodriguez-Abreu, et al. 2021. “Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel).” Current Oncology 28 (2): 1249–55. doi:10.3390/curroncol28020118.